Hai-O Enterprise Berhad operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hai-O Enterprise Berhad with three other
drug stores in Asia:
Hong Kong Life Sciences and Technologies Group Ltd
of Hong Kong
sales of 140.21 million Hong Kong Dollars [US$17.91 million]
of which 82%
was Trading Business),
Hua Xia Healthcare Holdings Limited
of Hong Kong
(330.46 million Hong Kong Dollars [US$42.21 million]
Hin Sang Group (International) Holding Co Ltd
based in Hong Kong
(188.55 million Hong Kong Dollars [US$24.08 million]
of which 96%
was Product Development Segment).
Hai-O Enterprise Berhad reported sales of 461.70 million Malaysian Ringgits (US$110.14 million)
April of 2018.
increase of 14.2%
versus 2017, when the company's sales were 404.24 million Malaysian Ringgits.
This was the third consecutive year of growth at Hai-O Enterprise Berhad.
Sales of Wholesale saw an increase
20.9% in 2018, from
52.65 million Malaysian Ringgits to 63.65 million Malaysian Ringgits.
Not all segments of Hai-O Enterprise Berhad experienced an increase in sales in 2018:
sales of Others fell 10.6% to 4.02 million Malaysian Ringgits.
(However, this segment's sales were only a very small portion of the company's overall sales).